Trademark Overview
On Tuesday, January 21, 2025, a trademark application was filed for ZIVIDAC with the United States Patent and Trademark Office. The USPTO has given the ZIVIDAC trademark a serial number of 99013386. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, January 21, 2025. This trademark is owned by ViiV Healthcare UK (No.3) Limited. The ZIVIDAC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives